-
Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into Tumorigenesis. Am J Surg Pathol. 2019;43(11): 1493-1500.
Saijo M, Nakamura K, Ida N, Nasu A, Yoshino T, Masuyama H, Yanai H.
-
Assessment of glucose kinetics with real-time continuous glucose monitoring during labor. J Obstet Gynaecol Res. 2019;45(9): 1851-1859.
Maki J, Eto E, Tamada S, Mitsui T, Hayata K, Nakamura K, Hiramatsu Y, Masuyama H.
-
Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia. Hypertension. 2019;74(1): 164-172.
Bian X, Biswas A, Huang X, Lee KJ, Li TK, Masuyama H, Ohkuchi A, Park JS, Saito S, Tan KH, Yamamoto T, Dietl A, Grill S, Verhagen-Kamerbeek WDJ, Shim JY, Hund M.
-
Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy. Anticancer Res. 2019;39(2): 933-939.
Matsuoka H, Nakamura K, Matsubara Y, Ida N, Nishida T, Ogawa C, Katsi K, Kanazawa S, Masuyama H.
-
Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT. Prenat Diagn. 2019;39(2): 100-106.
Suzumori N, Sekizawa A, Takeda E, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Kuriki H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Endo M, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Nishikawa N, Hamajima N, Shirato N, Yotsumoto J, Nishiyama M, Koide K, Hirose T, Sago H.
-
The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors. Int J Gynecol Cancer. 2018;28(7): 1394-1402.
Matsuoka H, Nakamura K, Matsubara Y, Ida N, Saijo M, Ogawa C, Masuyama H.
-
Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability. PLoS One. 2018;13(4): e0195655.
Haruma T, Nagasaka T, Nakamura K, Haraga J, Nyuya A, Nishida T, Goel A, Masuyama H, Hiramatsu Y.
-
Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2018;224: 165-169.
Suzumori N, Sekizawa A, Ebara T, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Izumi H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H.
-
Interaction between orexin A and bone morphogenetic protein system on progesterone biosynthesis by rat granulosa cells. J Steroid Biochem Mol Biol. 2018;181: 73-79.
Fujita S, Hasegawa T, Nishiyama Y, Fujisawa S, Nakano Y, Nada T, Iwata N, Kamada Y, Masuyama H, Otsuka F.
-
Assessment of resting energy expenditure and body composition in Japanese pregnant women with diabetes. J Diabetes Investig. 2018;9(4): 959-966.
Eto E, Maki J, Tamada S, Mitsui T, Hayata K, Hiramatsu Y, Masuyama H.
-
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy. Int J Gynecol Cancer. 2018;28(1): 168-175.
Kiyotoki T, Nakamura K, Haraga J, Omichi C, Ida N, Saijo M, Nishida T, Kusumoto T, Masuyama H.
-
The Influence of Adverse Effects on Quality of Life of Survivors of Gynecologic Cancer. Int J Gynecol Cancer. 2017;27(9): 2014-2019.
Omichi C, Nakamura K, Haraga J, Ida N, Saijo M, Nishida T, Kusumoto T, Masuyama H.
-
Reply to "Letter to the Editor" by M. Saijo et al. "Glasgow prognostic score is predictive of prognosis for patients with endometrial cancer Eur J Obstet Gynecol Reprod Biol. 2017;216: 260.
Saijo M, Nakamura K, Masuyama H, Ida N, Haruma T, Kusumoto T, Seki N, Hiramatsu Y.
-
Current status of non-invasive prenatal testing in Japan. J Obstet Gynaecol Res. 2017;43(8): 1245-1255.
Samura O, Sekizawa A, Suzumori N, Sasaki A, Wada S, Hamanoue H, Hirahara F, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Nakayama S, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Kido Y, Fukao T, Miharu N, Nagamatsu T, Watanabe A, Hamajima N, Hirose M, Sanui A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H.
-
Comparison of Kidney Function between Gestational Hypertension and Preeclampsia. Acta Med Okayama. 2017;71(2):161-169.
Nobumoto E, Masuyama H, Maki J, Eguchi T, Tamada S, Mitsui T, Eto E, Hayata K, Hiramatsu Y.
-
Glasgow prognostic score is a prognosis predictor for patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2017; 210: 355-359.
Saijo M, Nakamura K, Masuyama H, Ida N, Haruma T, Kusumoto T, Seki N, Hiramatsu Y.
-
Sex differences in early growth during the first three years of life in offspringfrom mothers with pregnancy-induced hypertension. Pregnancy Hypertens. 2016 Oct;6(4):361-366.
Mitsui T, Masuyama H, Eguchi T, Tamada S, Eto E, Hayata K, Hiramatsu Y.
-
Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer. Int J Gynecol Cancer. 2017 Jan;27(1):117-122.
Nakamura K, Masuyama H, Ida N, Haruma T, Kusumoto T, Seki N, Hiramatsu Y.
-
Sex differences in early growth during the first three years of life in offspring from mothers with pregnancy-induced hypertension. Pregnancy Hypertens 6: 361-366, 2016.
T. Mitsui, H. Masuyama, T. Eguchi, S. Tamada, E. Eto, K. Hayata, Y. Hiramatsu.
-
Return to work after cancer treatment of gynecologic cancer in Japan. BMC Cancer 16: 558, 2016.
K. Nakamura, H. Masuyama, T. Nishida, J. Haraga, N. Ida, M. Saijo, T. Haruma, T. Kusumoto, N. Seki, Y. Hiramatsu
-
Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high fat diet-fed pregnant mice via constitutive androstane receptor. Mol Cell Biochem 419: 185-192, 2016.
H. Masuyama, T. Mitsui, J. Maki, K. Tani, K. Nakamura, Y. Hiramatsu.
-
Japan NIPT Consortium: A survey on awareness of genetic counseling for non-invasive prenatal testing: The first year experience in Japan. J Hum Genet. 61:995-1001, 2016.
J. Yotsumoto, A. Sekizawa, N. Suzumori, T. Yamada, O. Samura, M. Nishiyama, K. Miura, H. Sawai, J. Murotsuki, M. Kitagawa, Y. Kamei, H. Masuzaki, F. Hirahara, T. Endo, A. Fukushima, A. Namba, H. Osada, Y. Kasai, A. Watanabe, Y. Katagiri, N. takeshita, M. Ogawa, T. Okai, S. Izumi, H. Hamanoue, M. Inuzuka, K. Haino, N. Hamajima, H. Nishizawa, Y. Okamoto, H. Nakamura, T. Kanegawa, J. Yoshimatsu, S. Tairaku, K. Naruse, H. Masuyama, M. Hyodo, T. kaji, K. Maeda, K. Matsubara, M. Ogawa, T. Yoshizato, T. Ohba, Y. Kawano, H. Sago.
-
Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anti-cancer agents in ovarian cancer cells. Int J Oncol 49: 1211-1220, 2016.
H. Masuyama, K. Nakamura, E. Nobumoto, Y. Hiramatsu.
-
The effects of paternal high-fat diet exposure on offspring metabolism with epigenetic changes in the mouse Adiponectin and Leptin gene promoters. Am J Physiol Endocrinol Metab 311(1): E236-245, 2016.
H. Masuyama, T. Mitsui, T. Eguchi, S. Tamada, Y. Hiramatsu.
-
Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy. J Hum Genet. 61(7): 647-652, 2016.
N. Suzumori, T. Ebara, T. Yamada, O. Samura O, J. Yotsumoto, M. Nishiyama, K. Miura K, H. Sawai H, J. Murotsuki J, M. Kitagawa M, Y. Kamei Y, H. Masuzaki, F. Hirahara F, JS. Saldivar , N. Dharajiya, H. Sago, A. Sekizawa A; Japan NIPT Consortium, T. Endo, A. Hukushima, S. Nanba, H. Osada, Y. Kasai, A. Watanabe, Y. Katagiri, N. Takesita, M. Ogawa, T. Okai, SI. Izumi, H. Hamanoue, K. Haino, N. Hamajima, H. Nishizawa, Y. Okamoto, H. Nakamura, T. Kanekawa, J. Yoshimatsu, S. Tairaku, K. Naruse, H. Masuyama, M. Hyodo, T. Kaji, K. Maeda , K. Matsubara, M. Ogawa, T. Yoshizato, T. Ohba, Y. Kawano.
-
Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer. Cancer Med 5(6): 1074-1080, 2016.
C. Ohmichi, K. Nakamura, J. Haraga, H. Masuyama, Y. Hiramatsu.
-
The effects of high-fat diet exposure in utero on the obesogenic and diabetogenic traits through epigenetic changes in Adiponectin and Leptin gene expression for multiple generations in female mice. Endocrinology 156(7): 2482-91, 2015.
H. Masuyama, T. Mitsui, E. Nobumoto, Y. Hiramatsu.
-
The inhibition of constitutive androstane receptor-mediated pathway enhances the effects of anticancer agents in ovarian cancer cells. Biochem Pharmacol 90: 356-366, 2014.
Y. Wang, H. Masuyama, E. Nobumoto, G. Zhang, Y. Hiramatsu.
-
Additive Effects of Maternal High Fat Diet during Lactation on Mouse Offspring. PLoS One 9(3): e92805, 2014.
H. Masuyama, Y. Hiramatsu.
-
Treatment with Constitutive Androstane Receptor Ligand during Pregnancy Prevents Insulin Resistance in Offspring from High- fat Diet-Induced Obese Pregnant Mice. Am J Physiol Endocrinol Metab 303(2): E293-300, 2012.
H. Masuyama, Y. Hiramatsu.